Bill

Bill > S5046


US S5046

US S5046
FDA Modernization Act 3.0


summary

Introduced
09/12/2024
In Committee
09/12/2024
Crossed Over
12/16/2024
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

AN ACT To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.

AI Summary

This bill, the FDA Modernization Act 3.0, requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish an interim final rule within one year of the bill's enactment. The rule will replace references to "animal" tests, data, studies, models, and research with "nonclinical" tests, data, studies, models, and research in various sections of the Code of Federal Regulations related to new drug applications and other FDA regulations. The bill also defines the term "nonclinical test" in the relevant sections of the regulations. Additionally, the bill makes a technical amendment to the Federal Food, Drug, and Cosmetic Act to designate a new subsection.

Committee Categories

Health and Social Services

Sponsors (10)

Last Action

Held at the desk. (on 12/16/2024)

Bill Topics

Health
  • ‐ Regulation of Drug Industry and Pharmacies
  • ‐ Research and Development

bill text


bill summary

Loading...

bill summary

Loading...
Loading...